Trials / Completed
CompletedNCT05143710
The Clinical and Prognostic Features of PRES
The Features of Clinical Imaging, Disease Severity and Pregnancy Outcomes in Posterior Reversible Encephalopathy Syndrome With Preeclampsia or Eclampsia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 354 (actual)
- Sponsor
- Dunjin Chen · Academic / Other
- Sex
- Female
- Age
- 16 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the features of clinical imaging, disease severity and pregnancy outcomes in posterior reversible encephalopathy syndrome with preeclampsia or eclampsia.
Detailed description
The investigators retrospectively collected data (General information, clinical data, biochemical indicators, imaging features, and pregnancy outcome) from pregnant woman diagnosed with PRES with preeclampsia or eclampsia to analyze features of clinical imaging, disease severity and pregnancy outcomes during 2012 to 2021.Then, the investigators grouped all the patients into early onset group and late onset PE group according to gestational weeks to analyze differences of clinical imaging. Finally, the investigators grouped all the patients into good pregnancy outcomes group and poor pregnancy outcomes group according to diagnostic criteria, including the incidence of stillbirth and premature birth, to analyze differences of clinical imaging .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PRES in PE or E | patients diagnosed with posterior reversible encephalopathy syndrome with preeclampsia or eclampsia |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2022-01-31
- Completion
- 2022-01-31
- First posted
- 2021-12-03
- Last updated
- 2022-03-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05143710. Inclusion in this directory is not an endorsement.